Today's News | Note: News feeds may no longer be available for the articles on this page.

Teva loses appeal in patent dispute with P&G 2:41 PM 5/13/2009
Forbes - NY,USA
Teva Pharmaceutical Industries said a US appeals court upheld a lower court's decision to stop generic versions of Procter & Gamble's osteoporosis drug Actonel (risedronate) until 2014. ...

Pozen says it will ask for pain drug approval 7:21 AM 5/13/2009
Forbes - NY,USA
Pozen Inc will ask the US FDA to approve its chronic pain drug candidate PN 400 it is developing with AstraZeneca. ...

Medicines Co. stops 2 anti-clotting drug trials 6:27 AM 5/13/2009P
Forbes - NY,USA
Medicines Co stopped late-stage testing of anti-clotting drug candidate cangrelor for failing to meet its goals in two clinical trials. ...

Health authorities prepare to limit flu drug use 4:50 AM 5/13/2009
Reuters - USA
Global health officials say that drugs used to treat H1N1 swine influenza should be limited to chronically ill, pregnant women, and other vulnerable patients. ...

AMAG says FDA accepts resubmission of anemia drug NDA 12:50 AM 5/13/2009
Reuters - USA
AMAG Pharmaceuticals said that the US FDA accepted the resubmission of the new drug application (NDA) for its experimental anemia drug ferumoxytol. The FDA will probably review the NDA within a 60-day period. ...

Blood-Thinning Drug Eyed in Hospital Deaths 5:41 AM 5/12/2009
NBC Philadelphia - Philadelphia,PA,USA
Three people suffered cerebral hemorrhaging after being given a pre-mix of heparin made by the Baxter Healthcare Corporation which sent representatives to the hospital. The US FDA is also investigating the deaths. ...

Targacept ADHD drug meets mid-stage goal, shares up 9:26 AM 5/11/2009
Reuters - USA
Targacept Inc said its drug AZD3480 gave patients statistically significant improvement in symptoms in a mid-stage study in adults with attention deficit/hyperactivity disorder (ADHD). ...

Lupin Settles Antidepressant Drug Litigation With Wyeth 4:12 AM 5/11/2009
Wall Street Journal - USA
India's Lupin Ltd has settled all ongoing litigation relating to Venlafaxine extended release capsules. ...

AstraZeneca's drug Brilinta beats Plavix in trial 2:22 AM 5/11/2009
Reuters - USA
AstraZeneca's experimental heart drug Brilinta (AZD6140) beat Sanofi-Aventis/Bristol-Myers Squibb Co's blockbuster Plavix (clopidogrel) in a head-to-head study of the two drugs. ...

Merck Wins Halt on California Vioxx Class-Action 6:38 AM 5/9/2009
Bloomberg - USA
Merck & Co won’t face a class-action lawsuit for costs tied to the painkiller Vioxx. Uniformity in how much plaintiffs paid for Vioxx is lacking. Each medical history and prescription decision is different. ...

New warnings for Tarceva cancer drug-US FDA 3:44 PM 5/8/2009
Reuters - USA
New warnings have been added to Genentech/OSI Pharmaceutical's cancer drug Tarceva to describe skin reactions, eye problems, and holes in the digestive tract. The US FDA said that patients have died in some cases. ...

Nycomed submits Daxas lung drug for EU approval 4:11 AM 5/8/2009
Reuters - USA
Nycomed submitted its "smoker's lung" drug Daxas for regulatory approval in Europe and is preparing for a submission in the United States. ...

Obama seeks FDA budget hike, generic drug fees 3:01 AM 5/8/2009
Reuters - USA
The proposal calls for $36 million from manufacturers to review generic versions of human drugs under the FDA's generic drug office. ...

Stent patients advised to switch heartburn drugs 9:52 PM 5/6/2009
Reuters - USA
Patients taking the blood thinner Plavix (clopidogrel) should avoid certain acid reflux drugs after a study showed that combining the two raises the risk of heart attack or stroke. Proton pump inhibitors (PPI) reduce the anti-clotting benefits of Plavix. ...

Vanda gets FDA nod for schizophrenia drug 6:56 PM 5/6/2009
Reuters - USA
Vanda Pharmaceuticals Inc said the US FDA approved its Fanapta (iloperidone) treatment for schizophrenia. ...

<- Day Earlier | Today's News